SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001867096-23-000024
Filing Date
2023-02-01
Accepted
2023-02-01 16:13:59
Documents
2
Period of Report
2023-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167528602235679.html 4  
1 FORM 4 wf-form4_167528602235679.xml 4 3768
2 SHANNON, JOHN PATRICK JR. POA ex-24.htm EX-24 3026
  Complete submission text file 0001867096-23-000024.txt   8205
Mailing Address DURATA THERAPEUTICS, INC. 89 HEADQUARTERS PLAZA NORTH, 14TH FLOOR MORRISTOWN NJ 07960
Business Address
Shannon John Patrick Jr (Reporting) CIK: 0001553595 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40880 | Film No.: 23576919

Mailing Address 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601
Business Address 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601 844-445-5704
Xeris Biopharma Holdings, Inc. (Issuer) CIK: 0001867096 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations